Ep. 485 Mastering Microwave Ablation in HCC Treatment with Dr. Zach Berman

04/10/2024 39 min
Ep. 485 Mastering Microwave Ablation in HCC Treatment with Dr. Zach Berman

Listen "Ep. 485 Mastering Microwave Ablation in HCC Treatment with Dr. Zach Berman"

Episode Synopsis

Are you up-to-date on microwave ablation for hepatocellular carcinoma (HCC) treatment? Dr. Zachary Berman and host Dr. Michael Barraza discuss this treatment modality. They cover the spectrum of pre-procedure imaging and planning, procedure steps, and tips for navigating difficult cases. Dr. Berman is a hepatobiliary interventional oncologist and Associate Clinical Professor of Radiology at UC San Diego School of Medicine.

---

This podcast is supported by an educational grant from Varian, a Siemens Healthineers company.

---

SYNPOSIS

Dr. Berman highlights the importance of a multidisciplinary approach, referral pathways, and the role of tumor boards in decision-making. The doctors also cover various ablation technologies, pre-procedure embolization, hydrodissection, biopsy considerations, and the incorporation of immunotherapy in ongoing research. Finally, Dr. Berman emphasizes the importance of ultrasound skills and presents some cases.

---

TIMESTAMPS

00:00 - Introduction
10:09 - Techniques and Technologies
17:26 - Planning and Performing Ablations
21:35 - Tumor Size and Margins
25:09 - Navigational Software and Skills
30:47 - Hydrodissection Techniques
33:20 - Post-Ablation Imaging and Follow-Up
35:52 - Future of Ablation in IR and Cases

---

RESOURCES

Liver Imaging Reporting & Data System (LI-RADS®):
https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADS

Liver Cancer Stages (BCLC):
https://www.cancer.gov/types/liver/what-is-liver-cancer/stages

Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795153/

Microwave ablation compared with radiofrequency ablation for treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698169/

Prospective double-blinded randomized controlled trial of Microwave versus RadioFrequency Ablation for hepatocellular carcinoma (McRFA trial):
https://www.hpbonline.org/article/S1365-182X(20)30023-X/fulltext

Percutaneous radiofrequency versus microwave ablation for management of hepatocellular carcinoma: a randomized controlled trial:
https://jgo.amegroups.org/article/view/26929/html
Surgical microwave ablation for the treatment of hepatocellular carcinoma in 791 operations:
https://www.sciencedirect.com/science/article/abs/pii/S1365182X23020002

Surgery versus thermal ablation for small-size colorectal liver metastases (COLLISION): An international, multicenter, phase III randomized controlled trial:
https://meetings.asco.org/abstracts-presentations/234189

One-millimeter cancer-free margin is curative for colorectal liver metastases: a propensity score case-match approach:
https://pubmed.ncbi.nlm.nih.gov/23732261/

More episodes of the podcast BackTable Vascular & Interventional